VALERIA SMITH to Humans
This is a "connection" page, showing publications VALERIA SMITH has written about Humans.
Connection Strength
0.093
-
Severe COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28710.
Score: 0.020
-
Clinical and molecular features of pediatric cancer patients with Lynch syndrome. Pediatr Blood Cancer. 2022 11; 69(11):e29859.
Score: 0.006
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.006
-
Severe Pediatric COVID-19 Pneumonia Treated With Adjuvant Anakinra. Hosp Pediatr. 2022 05 01; 12(5):e162-e170.
Score: 0.005
-
Angiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):e751-e755.
Score: 0.005
-
Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board. Pediatr Hematol Oncol. 2022 10; 39(7):678-680.
Score: 0.005
-
Philadelphia chromosome-positive pre-B lymphoblastic leukemia presenting as acute hepatic failure in a pediatric patient. Pediatr Hematol Oncol. 2022 08; 39(5):481-487.
Score: 0.005
-
Sclerosing Encapsulating Peritonitis in a Pediatric Patient Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Pediatr Hematol Oncol. 2021 07 01; 43(5):e685-e688.
Score: 0.005
-
Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience. Pediatr Blood Cancer. 2021 09; 68(9):e29173.
Score: 0.005
-
Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021 03; 68(3):e28778.
Score: 0.005
-
Neuroimaging Characteristics of Nasopharyngeal Carcinoma in Children. J Neuroimaging. 2021 01; 31(1):137-143.
Score: 0.005
-
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
Score: 0.005
-
Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14.
Score: 0.005
-
A 3-Week-Old With an Isolated "Blueberry Muffin" Rash. Pediatrics. 2017 Jul; 140(1).
Score: 0.004
-
Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017 Apr; 17(4):369-386.
Score: 0.004
-
The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692.
Score: 0.004